These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 937323)

  • 1. The treatment of patients with gallstones by lecithin.
    Tuzhilin SA; Dreiling DA; Narodetskaja RV; Lukash LK
    Am J Gastroenterol; 1976 Mar; 65(3):231-5. PubMed ID: 937323
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biliary lipids and the cholesterol saturation rate in relation to lecithin administration by oral route].
    Mamianetti A; Apud A; Dameno E; Lafont D; Díaz F; Lemos García M
    Acta Gastroenterol Latinoam; 1979; 9(2):89-94. PubMed ID: 506644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of conjugated bile acids in bile by high-pressure liquid chromatography. II. Clinical application in bile of patients with gallstones.
    Maruyama K
    Nihon Geka Hokan; 1982 Jan; 51(1):14-43. PubMed ID: 7092460
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Part II. The systemic treatment of gallstones.
    Tompkins RK
    Adv Surg; 1976; 10():87-98. PubMed ID: 824939
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol gallstones.
    Percy-Robb IW
    Scott Med J; 1973 Sep; 18(5):157-65. PubMed ID: 4201570
    [No Abstract]   [Full Text] [Related]  

  • 9. The biochemistry of gallstone formation.
    Bouchier IA
    Clin Gastroenterol; 1973 Jan; 2(1):49-66. PubMed ID: 4271976
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Is intermittent chenodeoxycholic acid therapy feasible for dissolving gallstones? The speed of change in biliary lipids and bile acids after starting and stopping treatment.
    Iser JH; Murphy GM; Dowling RH
    Gut; 1975 Oct; 16(10):840. PubMed ID: 1205324
    [No Abstract]   [Full Text] [Related]  

  • 11. [The dissolving of cholesterol gallstones. A current therapeutic problem].
    Erb W
    Med Klin; 1975 Jul; 70(28-29):1199-1207. PubMed ID: 1101004
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in biliary bile acid composition and cholesterol saturation of bile in patients with cholesterol gallstones following treatment with ursodeoxycholic acid].
    Stiehl A; Czygan P; Fröhling W; Kommerell B
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():501-2. PubMed ID: 612017
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholelithiasis treated with chenodeoxycholic acid. An analysis of changes in the pattern of bile acids (author's transl)].
    Hrabák P; Dosková M; Soucková E
    Cas Lek Cesk; 1981 Jul; 120(27):817-23. PubMed ID: 7261002
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dissolution of gallstones: reality and prospects].
    Dederer IuM
    Klin Med (Mosk); 1980 May; 58(5):16-21. PubMed ID: 6991803
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholesterol kinetics in patients with cholesterol gallstones before and during chenodeoxycholic acid treatment.
    Pedersen L; Arnfred T; Thaysen EH
    Scand J Gastroenterol; 1974 Nov; 9(8):787-91. PubMed ID: 4610716
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic morphology and bile acid composition of bile and urine during chenodeoxycholic acid therapy for radiolucent gallstones.
    Pedersen L; Bremmelgaard A
    Scand J Gastroenterol; 1976; 11(4):385-9. PubMed ID: 935799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution of gallstones with bile salts, lecithin, and heparin.
    Cheung LY; Englert E; Moody FG; Wales EE
    Surgery; 1974 Sep; 76(3):500-3. PubMed ID: 4851407
    [No Abstract]   [Full Text] [Related]  

  • 19. Criteria for selection of patients for medical treatment (chenodeoxycholic acid therapy) of gallstones.
    Bruusgaard A; Malver E; Pedersen LR; Schlichting P; Sylvest J
    Scand J Gastroenterol; 1977; 12(1):97-102. PubMed ID: 834976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary excretion of bile acids, lecithin, and cholesterol in hamsters with gallstones.
    Wheeler HO
    Gastroenterology; 1973 Jul; 65(1):92-103. PubMed ID: 4720825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.